Eli Lilly has shared one-year histologic outcomes from a phase 3 study of its interleukin-23p19 antagonist mirikizumab in ...
A US Food and Drug Administration (FDA) panel of experts has voted in support of Stealth BioTherapeutics’ elamipretide for ...
Up to 20% of patients will develop metastatic castration-resistant disease within five to seven years of diagnosis ...
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster.
Halo BioConsulting Ltd Halo BioConsulting is a pharmaceutical business development consulting firm providing a broad portfolio of commercial and transactional advisory services to pharmaceutical and ...
Moorfields Pharmaceuticals is the manufacturing arm of Moorfields Eye Hospital NHS Foundation Trust. We produce nearly 100 ophthalmic specials and have a growing portfolio of branded licensed products ...
LONDON--(BUSINESS WIRE)--The Women’s Brain Foundation (WBF), the global pioneer that has advanced the inclusion of sex- and gender-based evidence-generation in all research, drug development, and ...
Whether its working with pharmaceutical, CRO, biotech organisations & medical communications agencies covering Clinical Research, Regulatory Affairs, Biometrics, Pharmacovigilance, Medical Affairs and ...
We are 20:20 Selection. Over more than 10 years we have built our reputation in providing unrivalled professional medical recruitment services to both our clients and candidates. During that time we ...
Helping organisations to meet their communications challenges. We bring together the best teams to deliver fantastic outcomes for our clients.
FRONTERA GROUP is a cross-functional blend of behaviour and creative engagement experts. Our approach identifies the underlying drivers of decision making, to uncover how choices are made today and ...
Gower is recognised as one of the world’s leading publishers of specialist business and management books and resources. Our publishing programme covers many of the main business processes and ...